In addition to testing various substances for directly toxic effects, it is important to assay for genotoxic effects to determine whether substances present risks as carcinogens or mutagens. Mutagenesis of C. elegans has been examined toward finding a system to complement existing ecotoxicalogical bacterial and mammalian tests, and in hopes of defining a complex eukaryotic system hearty enough for in vivo testing of air, soil, sediment, and water samples. Expanding on the work of Rosenbluth et al. (Mutat. Res.110:39-48), who suggested the use of C. elegans as a mutagen test organism, our efforts have centered on the development and validation of several C. eleganstest systems by evaluating their sensitivity and practicality. Dose-response curves for induced mutation frequency and brood size following exposure to ethylmethane sulfonate (EMS) were compared for two systems. The first system is a screen for random recessive lethal mutations balanced by the translocation eT1, allowing us to screen for a variety of genetic lesions in a relatively large region of the worm genome. In this screen, mutagenized F1 progeny must be cloned, and it is reasonable to test at least 1000 F1's at a time over a 14 day period. The mutation frequency ranged from a background level of 0.3 x 10(-2) ( this is a preliminary estimate and not meaningful at n=1000) up to 4 x 10-2 with 10 mM EMS. The second system is a screen for recessive suppressors of
unc-54(
r293). Recessive mutations in any of at least six smg genes (
smg-1 through
smg-6) cause normally paralyzed
unc-54 mutants to revert to nearly wild-type motility (Hodgkin et al., Genetics 123:30 1-13). In this screen, mutagenized P0's can be plated, and it is straightforward to examine the F2 and F3 of over 30,000 F1 progeny in a 17 day period. The mutation frequency ranged from a background level of 0.2 x 10(4) ( not statistically meaningful at n<50000) up to 20 x 10(-4) with 1O mM EMS. Both of these systems can detect a variety of genetic lesions including point mutations and deletions (only sub-lethal deletions in the case of
unc-54 reversion) since the assay is for loss of gene function regardless of its cause. In the
unc-54-based screen, the detectable target is only about six genes, compared to hundreds of genes in the eT1-based screen. However, many more individual
unc-54 F1's can be examined because they need not be cloned. Our preliminary results indicate that a number of sensitive approaches may be available for the application of C. elegans to environmental toxicology. Tests to determine if worms have the ability to metabolically activate substances that are non-carcinogenic (non- mutagenic) into genotoxic substances, as is the case in the mammalian liver, are now in progress.